These results suggest that YY1 may play a role in NPM gene expression. This is the first report on human NPM gene structure and sequence.
INTRODUCTION
Nucleophosmin (NPM, also called protein B23, numatrim, NO38) is a nucleolar phosphoprotein 20 times more abundant in cancer cells than in normal resting cells (1) . Its putative function is the assembly and/or transport of ribosome. NPM is a mobile protein; its cellular localization is affected by growth conditions and influenced by certain cytotoxic drugs. During serum starvation (2) or treatments with anticancer drugs-daunomycin, actinomycin D, camptothecin or toyocamycin-it shifts from nucleoli to nucleoplasm (NPM-translocation) (3) (4) (5) (6) (7) . The cellular location of NPM is also dependent on GTP and ATP levels. When the de novo synthesis of GTP is inhibited and cells are depleted of GTP, NPM-translocation occurs (8) . On the other hand, when ATP levels are depleted, NPM-translocation is blocked and newly synthesized ribosomal RNA accumulate in nuclei and cannot be transported to the cytoplasm (9) (10) . NPM is associated with pre-ribosomal particles and other nuclear proteins as well. The proteins it associates with include transcription factor YY1 (11), nucleolar p120 protein (12) and HIV protein Rev/Rex (13) (14) .
NPM biosynthesis is related to cell proliferation and mitogenesis. We found that NPM mRNA is 50-fold higher in Novikoff hepatoma and 5-fold higher in hypertrophic rat liver than in normal rat liver (1). Feuerstein et al. (15) (16) reported that when B cells, T cells and Swiss 3T3 cells were stimulated with various mitotic agents, NPM synthesis increased. On the other hand, down regulation of NPM was observed in Jurkat T-lymphoblasts during apoptosis (17) . These studies indicate that NPM expression is associated with cell growth.
The rat NPM gene has been isolated and characterized (18) . However, the structure and sequence of the functional human NPM gene is not yet known. Previously, we identified seven human processed pseudogenes of NPM (19) . Genomic blot analysis indicated that there are at least 10 copies of NPM gene per haploid human genome. With the recent information that the chromosome breakpoints of t(2:5), t(5:17) and t(3:5) chromosome translocation associate with NPM gene (19) (20) (21) (22) (23) (24) (25) , we searched for the functional gene in the human chromosome 5 library and isolated four clones. Here, we report the gene's physical structure and DNA sequence. The 5′ region and the DNA sequence of the intron 4 where t(5:2) chromosome break occurs were characterized. This is the first report on human NPM gene structure and sequence. We also found that the transcription factor YY1 (26) (27) (28) (29) binds to the 5′ region of the NPM gene, suggesting that YY1 may play a role in NPM gene expression.
MATERIALS AND METHODS

Genomic sequences analysis
A human chromosome 5 genomic library was obtained from the American Type Culture Collection (cat. no. LA05NL03). The library was screened with cDNA probes (1) and the first intron probe (p16-3/1.2S) derived from the chromosome walk (20) . Screening libraries, Southern blot analysis, DNA cloning, PCR and DNA sequencing by dideoxynucleotide termination reactions were performed according to the standard methods described in Sambrook et al. (30) . Primers used in PCR and in cloning were derived from various regions of the cDNA.
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Determination of the initiation site
To identify the initiation site, the primer extension method was employed. Antisense primer P5 (1-17 from the ATG site of cDNA) was end-labeled with [γ-32 P]ATP by polynucleotide T4 kinase. RNAs were prepared from HeLa cells using the GIBCO/ BRL Trizol reagent. Poly-A RNA were purified with oligotex-dT gel. Annealing of the primer to RNA was conducted at 43_C for 8 h. Primer extension was carried out by AMV reverse transcriptase at 42_C for 90 min. The primer extended fragment was analyzed in an 8% sequencing gel with both markers and a sequence ladder derived from the P5 primer.
Electrophoretic mobility shift assay (EMSA)
The procedure of EMSA was according to 'Current Protocol, vol II' (31) with slight modifications. DNA fragments, P (-249 to +465) and E (-741 to -250), were prepared by cleavages of the 5′ DNA with MluI (which cleaves at -249) and SacI (which cleaves at -741 and +465) restriction enzymes. The reaction mixture (25 µl) containing the MCF-7 or HeLa cell nuclear (32) extract (1-3 µg protein), end-labeled DNA fragments (0.5-5 ng), binding buffer [12 mM HEPES, pH 7.9, 4 mM Tris-HCl, 60 mM KCl, 1 mM DTT, 1 mM EDTA, 0.05% NP-40, 5 mM MgCl 2 , (MgCl 2 is required for YY1 binding), 12% glycerol], poly dI-dC (1.5 µg per reaction), BSA (300 µg/ml) " competitors, were incubated at 25_C for 15 min. The mixture was loaded onto a 4% polyacrylamide gel for electrophoresis. Retardation of DNA fragments due to binding of protein factors was detected by autoradiography.
DNase I footprinting
DNA fragment E was end-labeled either by T4 kinase or Klenow reaction. The labeled DNA was incubated with nuclear extracts (3-15 µg) in a final volume of 50 µl containing 12 mM HEPES, pH 7.9, 4 mM Tris-HCl, 60 mM KCl, 1 mM DTT, 1 mM EDTA, 12% glycerol and 2 µg of poly(dI-dC) and BSA (100 µg/ml). After 15 min of incubation at 25_C, DNase I (0.5-1.5 unit) was added to the mixture and allowed to digest for 1-1.5 min at 0_C. The reaction was stopped and precipitated by adding ethanol/ tRNA/ammonium acetate buffer mixture (31) . The reaction product was analyzed by a 6% polyacrylamide-8 M urea gel. The position of the footprint was determined by an adjacent sequencing gel ladder (33) .
Construction of 5′ deletion mutants and luciferase assay
Three DNA fragments from the 5′ region of the NPM gene: I (-741/+93), II (-405/+93) and III (-43/+93, which is the basal promoter with a TATA box) were prepared by PCR with appropriate primers. The 3′ end of these clones is located 3 bases upstream from the ATG site. These DNA fragments were subcloned into the luciferase reporter gene vector pXP1 (33) and were transfected into HeLa cells by electroporation (34) under the following conditions: 1.5 kV/cm, 1 ms pulse width, 2 trains with 15 pulses. Cells were cultured in Petri dishes (35 mm) for 48 h before harvest. Under these conditions, ∼20% of cells were transfected. Luciferase activity (RLU, relative luciferase unit) was determined with a Luminometer using D-lucuferin as substrate. The luciferase activity for each sample was normalized with their co-transfected β-galactosidase activity (RLU/β-gal unit) which was determined by the ONPG colorimetric assay.
RESULTS
Gene structure of human NPM
About 2 × 10 5 plaques from the human chromosome 5 library were screened (see Materials and Methods). Four clones were identified and purified which have inserts of 13-20 kb. Restriction mapping and Southern blot analysis with probes derived from the 5′ and 3′ region of the NPM cDNA indicated that three clones (A, B and C) contained the 5′ portion of the NPM gene and one clone (D or clone 21-3) (20) contained the 3′ region. The inserts of these clones were fragmented with restriction enzymes and subcloned into Bluescript SK vectors. Subcloning of individual introns was also achieved through PCR techniques using cDNA primers. The DNA sequences of these clones were determined. Figure 1 shows the restriction enzyme sites, the relative size and the location of exons in clones C and D. More than 60% of the gene sequence has been determined (sequences have been submitted to the GenBank). Since some of the intron sequences (except introns 3, 4 and 5) were not fully determined, the relative position between exons was determined by PCR with cDNA primers and by restriction mapping. Clone C contains exons 1-6 and clone D contains exons 7-11. The combined sequence of the NPM gene in clones C and D span ∼25 kb. Since the overlapping sequence has not been found between the 3′ of the C clone and the 5′ of the D clone, the estimated total length of the NPM gene could be >25 kb. There are 12 exons with sizes ranging from 58 (exon 7) to 358 bp (exon 12). The DNA sequences of the exons are identical to the cDNA sequence (1) except that the exon 11 is not identified in the major gene product. Table 1 shows the exon/intron junctions of the human NPM gene. The same exon/intron junctions are observed in the rat NPM gene (18) . Figure 2A shows the DNA sequence of the 5′ region of the NPM gene and Figure 2B shows the sequence of the intron 4 where the chromosome breaks occur (discussed in the following). The upper rows are the human sequences, the lower rows are the rat sequences; upper case letters represent the exon sequences; lower case letters represent the intron sequences. The difference between human and rat NPM coding sequences were underlined.
Location of the chromosome break point
It was recently discovered that the 5′ region of the NPM gene is fused with other genes in lymphoma cells having t(2:5), t(5:17) or t(3:5) chromosome translocation (20) (21) (22) (23) (24) (25) . Based on the RT-PCR transcript sequence of the fusion protein derived from cells with t(2:5) and t(5:17) chromosome translocation (20, 24) , the N-terminal 117 amino acids of NPM are fused to anaplastic lymphoma kinase (ALK) or retinoic acid receptor alpha (RARA). In t(3:5) chromosome translocation, the N-terminal 175 amino acids of NPM are fused to myepodysplasia leukemia factor 1 (MLF) (25) . Compared to the cDNA sequence (1) and exon/intron positions of human NPM gene (Table 1 and Fig. 1 ), the 117 and 175 amino acids of NPM are located at the junctions of exon 4/exon 5 and exon 6/exon 7, respectively. Accordingly, the chromosome breakpoint for t(2:5) and t(5:17) translocation is within intron 4 and the breakpoint for t(3:5) translocation is within intron 6. The precise breakpoint location within these introns is not known. Intron 4 is 911 bp long (Fig. 2B ). Sequence analysis indicated that this intron contains two Alu sequences (dotted underlines) which have 70-80% sequence homology to the Alu sequences observed in human ABL and BCR (break point cluster regions) genes (36) . We also found that the 3′ end of this intron is particularly enriched in T (denoted with italic).
Identification of the initiation site and sequence analysis of the 5′ region of NPM gene
To identify the initiation site for NPM transcription, the primer extension method was employed. Figure 3 shows the autoradiograph of the primer extended DNA fragments. We found one major and three minor primer extended fragments with lengths of 111, 112, 113 (major) and 114 bp. Compared to the adjacent sequencing gel, the major fragment (113 bp long) extended to the cytosine (C) at 96 bp upstream from the ATG site. Accordingly, the initiation site (+1) is assigned to this position ( Fig. 2A) . A well defined TATA box (TATATAA) and a GC box (GGCG) were observed at -25 nt and -66 nt, respectively ( Fig. 2A) . Sequence analysis with a computer search program identified four potential cis-elements upstream from the promoter region. They are (i) E1A-F (AGGA-CGT) (37) at -293; (ii) UCR core (CGCCATTTT) (26) at -352; (iii) ZRE-1 (TTACACA) (38) at -377; and (iv) UBP-1 (CTCTCT-GG) (39) , located at -414 and -550.
Electrophoretic mobility shift assay (EMSA)
To identify proteins that bind to the 5′ region of the NPM gene, an electrophoretic mobility shift assay (EMSA) was employed. Two DNA fragments (P and E) were used (Fig. 1) . Fragment P (-249 to +465) contains the TATA box, the GC box and part of the first intron. Fragment E (-741/-250) is located 5′ from fragment P. Nuclear protein extracts of HeLa or MCF-7 cells were incubated with the DNA fragments. Retardation of these fragments by proteins was identified (Fig. 4) . One gel-shift band (arrow) was identified using fragment P (Fig. 4A) , and two gel-shift bands (A and B) were identified using fragment E (Fig. 4B) . Formation of these gel-shift bands was not affected by competition with non-specific competitors: calf thymus DNA (which was sheared to sizes ∼500 bp), poly dI-dC/poly dI-dC and BSA, but was competed out by the unlabeled DNA fragments. Figure 3 . Determination of the initiation site. The primer extended DNA fragment (lane P) was analyzed on a 8% sequencing gel. Lane M has DNA size-markers; lanes G, A, T and C represent the nucleotide sequence of the 5′ region determined by dideoxynucleotide chain-termination method using the same primer. Compared to the adjacent sequencing gel and the markers, the major fragment (113 bp long) corresponds to an extension to 96 bp from the ATG site.
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Identification of protein binding site by footprinting analysis
To determine the DNA region that bound to protein(s), DNase I footprinting technique was employed. Fragment E was end labeled with [γ-32 P]ATP and incubated with the nuclear extract of MCF-7 cells. The DNA region protected by proteins was determined by DNase I digestion and footprinting analysis. As shown in Figure 5 , a footprint was identified from -371 to -344 with the sequence of GGGCTGCCGACGCCATTTTGCAGGGTGG (NPM-cis-1). To study whether the protein(s) protecting this region is related to the gel-shift band(s) observed in EMSA (in Fig. 4B ), a double-stranded DNA oligo with the footprint sequence (NPM-cis-1) was made and used as a competitor in EMSA. As shown in Figure 6 , this synthetic oligo effectively competed against the protein binding of fragment E in EMSA (lane 2-8). Both the major and minor gel-shift bands (proteins A and B) were effectively competed off by the oligo (12.5 ng). A modified oligo [NPM-cis-A, of which three Gs in the nonconsensus region of NPM-cis-1 are removed and inserted into the consensus region of the NPM-cis-1, (see Table 2 )] was not effective in competition (lane [10] [11] [12] [13] [14] [15] [16] . This result indicates that a specific DNA sequence is required for the binding of proteins A and B.
YY1 binds to NPM-cis-1 and fragment E
The footprint (NPM-cis-1) has the sequence CCATTTTG which is a potential binding site for the zinc finger DNA binding protein, YY1 (δ factor, UCRBP, NF-E1) (26) (27) (28) (29) . Table 2 shows the comparison of this sequence to other sequences that associate with protein YY1. To confirm whether YY1 is involved in the binding of DNA and causes the gel-shift, recombinant His-YY1 (a gift from Dr E. Seto) was employed in EMSA. Purified His-YY1 (a single band in SDS gel with >95% pure) was incubated with the end-labeled oligo NPM-cis-1. As shown in Figure 7 , YY1 caused the gel-shift of NPM-cis-1 (lane 2). Compared to the gel-shift band positions induced by the nuclear protein extract which produced a major and a very weak minor band (lane 3), the band produced by YY1 corresponded to the major band. The slightly slower mobility of the YY1 shifted band could be due to a small difference in the charge and M.W. of the recombinant His-YY1. However, this difference in mobility was This could be due to a partial dissociation of the immuno-complex under high ionic strength PAGE conditions (31) . The supershift is specific because normal rabbit serum or purified rabbit IgG (lanes 6,7) had no such effect. These results indicate that YY1 binds to the footprint sequence NPN-cis-1. a Double-stranded oligo NPM-cis-A was modified from NPM-cis-1 by rearranging three Gs in the nonconsensus region (underlined) to the consensus region (denoted by lower case letters).
The binding of purified YY1 to DNA fragment E was also studied with EMSA. We found that YY1 shifted fragment E to the major band position (protein A) like the nuclear protein did (data not shown). We also found tht addition of YY1 to the nuclear extract enhanced the intensity of the major band (data not shown).
These results indicated that the major band was a result of binding to YY1.
Expression of the 5′ deletion mutant of NPM gene
A luciferase reporter gene assay was employed to study the 5′ DNA domain(s) for NPM expression. The 5′ deletion mutants of NPM gene were subcloned into the luciferase reporter gene vector pXP1 (34) . These constructs were transfected into HeLa cells and the expression of luciferase activity was determined (Materials and Methods). As shown in Figure 8 , the promoter/ enhancer activity with the DNA sequence up to -405 (fragment II) including the YY1 binding site (-361/-353) is 93.19 " 19.45 × 10 6 RLU/β-gal unit. This activity is 157 times higher than the basal promoter (fragment III) activity (0.59 " 0.12 × 10 6 RLU/β-gal unit). It was also found that the construct with fragment I (which extended from -405 to -741) has a lower activity (48.01 " 9.8 × 10 6 RLU/β-gal unit), indicating a possible negative regulator element in the region between -741 and -405.
DISCUSSION
Sequence comparison between human and rat NPM genes
The exon/intron junctions for the human NPM gene are identical to those of the rat NPM gene ( Table 1 ). The number and the size of exons between human and rat NPM are the same, although the human gene spans >25 kb while the rat gene spans ∼11 kb. Many repetitive sequences were found in the introns of the human gene. While the sequence homology between the coding portions of human and rat NPM is ∼94%, we observed only 75% sequence homology in the 5′ noncoding region, the promoter and the enhancer regions. Chang and Olson (40) identified two NPM cDNA clones (B23.1 and B23.2) from rat tissues. The long form (B23.1) contains exons 1-9 and 11-12, and the short form (B23.2) contains exons 1-10. The short form of NPM (B23.2) is a result of alternative splicing of the NPM gene (18) . A sequence corresponding to the rat's exon 10 (expressed in the short form) was also identified in the human NPM gene (with 80% sequence homology). The expression of exon 10 in human tissue is not known and remains to be investigated. Intron 4 of the human NPM gene where chromosome break occurs (discussed below) is longer (911 bp) than the corresponding rat sequence (558 bp), but there is no sequence homology between them.
Sequence analysis of intron 4, chromosome breakpoint
NPM gene rearrangement is observed in certain types of non-Hodgkin's lymphoma (20) (21) (22) (23) (24) (25) . The 5′ portion of the NPM gene (in chromosome 5) is fused to other genes in t( (9-17 Ts) at the 3′ end (Fig. 2B) . The Alu sequences have 70-80% sequence homology to the Alu sequences observed in the human ABL and BCR genes (36) . The T-stretches at the 3′ end may facilitate triplet formation (42) , altering the DNA structure to favor breakage.
It is hypothesized that abnormal expression of genes due to gene rearrangement may affect normal cell growth and differentiation. The NPM promoter may cause overproduction of hybrid proteins which have tyrosine kinase (ALK) or retinoic acid receptor activities. These hybrid proteins may play a role in tumorigenesis. It was reported that over-expression of the NPM-ALK hybrid protein caused a malignant transformation of NIH 3T3 cells (43) .
Analysis of the 5′ region of the NPM gene
As a first step toward understanding NPM gene regulation and expression, we investigated protein bindings in the 5′ region of the NPM gene with EMSA and footprinting analysis. With DNA fragments E (-741/-250) and P (-249/+465), we identified three DNA binding proteins (Fig. 4) . Footprint analysis and competition EMSA (Figs 5 and 6 ) showed that the binding site for proteins A and B is between -371/-344. We identified that protein A is YY1. The binding of YY1 to this sequence is specific because a modified oligo (NPM-cis-A) with changes in the consensus sequence could not effectively compete for its binding to YY1 (Fig. 6 ). YY1 is a zinc finger transcription factor that binds to promoters and enhancers of many viral or cellular genes (27) (28) (29) . Depending on which proteins it associates with, YY1 can either be a positive or negative factor (27) (28) (29) 44) . It is also reported that binding of YY1 bends the DNA near the promoter/enhancer region which facilitates the interaction of protein factors on either side of its binding site (45) .
There are three potential factor binding sites around the YY1 binding site (Figs 1 and 2) . They are (i) E1A-F binding site (AGGACGT) (37) , located at -294; (ii) ZRE-1 site (TTACACA) (38) , located at -377; and (iii) two copies of UBP-1 binding site (CTCTCTGG), located at -414 and -550 (39). E1A-F, ZRE-1 and UBP-1 are cellular proteins which bind to enhancer elements and activate viral gene expression. One could speculate, based on this observation, that the factors responsible for viral gene activation may also affect NPM gene expression. Nonetheless, the bending of DNA (45) in the enhancer/promoter region of NPM gene by YY1 could help to facilitate interactions among factors and eventually control NPM gene expression. Our finding that YY1 binds to the 5′ region of the NPM gene is particularly significant, since YY1 is also found to associate with NPM protein (11) . These findings suggest that NPM may be involved a feedback control mechanism.
